Breast imaging market seen rising to $7.78 billion by 2030

The breast imaging technologies market is projected to grow from $5.21 billion in 2025 to $5.64 billion in 2026, with continued expansion expected through 2030. The report ties the outlook to rising breast cancer screening demand, AI adoption, and broader use of advanced imaging tools.

Why it matters: - Breast imaging technologies are central to earlier breast cancer detection, diagnosis and staging, which can improve treatment outcomes. - The market’s growth signals more demand for screening infrastructure, imaging software and advanced diagnostic tools worldwide. - Rising breast cancer incidence is keeping pressure on health systems to expand access to faster and more accurate imaging.

What happened: - The Business Research Company released a breast imaging technologies market report on July 29, 2026. - The report estimates the market will rise from $5.21 billion in 2025 to $5.64 billion in 2026. - The report forecasts the market will reach $7.78 billion by 2030. - The forecast implies an 8.1% CAGR in the historical period and an 8.4% CAGR through 2030.

The details: - The report links recent growth to expanded breast cancer screening programs, greater awareness of early diagnosis, more diagnostic imaging centers and wider adoption of digital mammography systems. - Improvements in imaging resolution also supported market expansion. - Future growth is expected to come from AI-based diagnostic tools, non-invasive imaging methods, personalized oncology treatment, imaging infrastructure investment and multimodal imaging platforms. - Key trends include AI-assisted breast imaging systems, 3D mammography, improved breast MRI, image-guided biopsy technologies and a stronger focus on early cancer detection. - The report defines breast imaging technologies as diagnostic radiology and medical imaging methods used to detect abnormalities in breast tissue at early stages. - These technologies are especially important for women with dense breast tissue and for evaluating mammography and breast ultrasonography results. - The report says the increasing incidence of breast cancer is a primary demand driver. - The American Cancer Society projected in May 2025 about 316,950 new invasive breast cancer cases in US women and 59,080 new DCIS cases. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The regional analysis also covers Southeast Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report’s 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, and updated graphics and tables. - A free sample and the full report are available as a free sample report and the full market report.

Between the lines: - The market outlook suggests breast imaging is shifting from a standalone diagnostic category toward a more software-enabled and multi-modality workflow. - AI and 3D imaging appear to be moving from emerging features to expected standards in future breast screening systems. - Growth in Asia-Pacific could reflect broader screening expansion and healthcare investment, though the report does not break out the specific country drivers.

What's next: - Demand will likely track continued growth in screening programs, cancer incidence and adoption of advanced imaging systems. - The report’s 2030 forecast leaves room for further gains if AI tools and multimodal imaging are adopted faster than expected. - Health providers and device makers will likely use the new forecast tools and regional analysis to guide investment and market entry decisions.